Meropenem and Piperacillin Plasma Concentrations During CRRT (ABC2)

Karolinska University Hospital

Status: Completed

Conditions: Hemolysis; Antibiotic; Infection; Renal Replacement Therapy; Sepsis

Treatments: Other: Plasma concentration measurements

Study type: Observational

Funder types: Other

Identifiers

NCT04203784

K 2019-9604

Details and patient eligibility

About

This observational study reports meropenem and piperacillin plasma concentrations in patients treated with either antibiotic and simultaneous continuous renal replacement therapy (CRRT).

Enrollment: 135 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• patients treated in the study ICU and
• simultaneous CRRT and antibiotic treatment with either meropenem or piperacillin-tazobactam.

Exclusion criteria

• none

Trial design

135 participants in 2 patient groups

Meropenem treated patients

Treatment:

Other: Plasma concentration measurements

Piperacillin treated patients

Treatment:

Other: Plasma concentration measurements